[1]常佳婧,王晞星,何院生,等.名医治疗肺癌气阴两虚兼痰瘀毒结证用药规律数据挖掘研究[J].中国中医药信息杂志,2020,27(7):120-124.[doi:10.3969/j.issn.1005-5304.201906265]
 CHANG Jiajing,WANG Xixing,HE Yuansheng,et al.Study on Data Mining of Medication Laws of Famous TCM Doctors for Treatment of Lung Cancer with Qi-yin Deficiency and Phlegm-stasis-toxin Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):120-124.[doi:10.3969/j.issn.1005-5304.201906265]
点击复制

名医治疗肺癌气阴两虚兼痰瘀毒结证用药规律数据挖掘研究

参考文献/References:

[1] LIU Y, YU S, LIU S, et al. Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations:a meta-analysis[J]. Sci Rep,2015,5:10516.

[2] BRONTE G, ROLFO C, PASSIGLIA F, et al. What can platinum offer yet in the treatment of PS2 NSCLC patients:a systematic review and meta-analysis[J]. Crit Rev Oncol Hematol,2015,95(3):306-317.

[3] 刘林涛,方志军,徐荷芬,等.养阴补肺解毒方治疗肺癌传承心悟[J].中国中医基础医学杂志,2018,24(10):1487-1488.

[4] 陈红,杨永,孙旭,等.抗癌解毒、化痰祛瘀治疗小细胞肺癌[J].中医杂志,2018,59(23):2061-2063.

[5] 张维骏,侯建春,王艳,等.路志正运用益肺化积汤治疗肺癌经验[J].中医杂志,2018,59(4):289-291.

[6] 王珊珊,郭茗,朱垚,等.国医大师周仲瑛教授辨治肺癌经验[J].中华中医药杂志,2015,30(12):4332-4335.

[7] 国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2015.

[8] 钟赣生.中药学[M].北京:中国中医药出版社,2016.

[9] 张星星,李泽庚.肺癌中医病因病机探讨[J].中华中医药杂志,2015, 30(10):3447-3449.

[10] LIN L Y, CHENG K L, HE Z, et al. A polysaccharide from Hedyotis diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting EMT via EGFR/Akt/ERK signaling pathways[J]. International Journal of Biological Macromolecules, 2019,2:706-714.

[11] 唐晓勇,唐迎雪,许鹏,等.浙贝母碱对A549/顺铂耐药肺癌细胞株核苷酸ERCC1基因及LRP表达的影响[J].中国中西医结合杂志,2015, 35(12):1490-1494.

[12] 何冰倩,周小杰,史冬玲,等.麦冬皂苷B抗肿瘤作用机制研究进展[J].中国中医药学刊,2018,36(12):2911-2914.

[13] 李杨,杨玲玲,白彦丽.黄芪多糖对气阴两虚Lewis肺癌荷瘤小鼠肿瘤生长、转移及细胞周期的影响[J].肿瘤防治研究,2018,45(3):131-137.

[14] 陈志强,张英志.莪术多糖对Lewis肺癌小鼠的抑制作用及机制[J].中国老年学杂志,2015,35(7):1925-1927.

[15] WE K, ZHOU J H, CHEN Y C, et al. Effects of pachyman in combination with vinorelbine and cisplatin on tumor growth and the expression of EGFR and K-ras in mice with lung cancer[J]. Digital Chinese Medicine,2018,4:310-315.

[16] 周斌,单泽松,方媚媚,等.六君子汤加减辅助化疗治疗晚期非小细胞肺癌31例临床观察[J].中医杂志,2015,56(3):219-222.

[17] 牛建旭,王忠太.中西医结合治疗慢性阻塞性肺疾病肺气肿表型39例临床观察[J].新中医,2018,50(12):75-78.

[18] 孙卓琳,刘京伟,匡长春.苦杏仁苷抑制人肺癌NCI-H1299细胞体外侵袭的机制[J].中国药科大学学报,2016,47(4):479-482.

[19] 朱大诚,肖威.蟾酥抗肿瘤作用及其机制研究进展[J].时珍国医国药,2017,28(6):1441-1444.

[20] 肖岚,彭壮,易健,等.玉竹多糖抗肺癌肿瘤活性及其机制研究[J].时珍国医国药,2018,29(10):2368-2372.

相似文献/References:

[1]曾柏荣,王理槐,孙银辉.扶正口服液对气阴两虚型Ⅲ-Ⅳ期肺癌患者化疗毒副反应的影响[J].中国中医药信息杂志,2013,20(12):73.[doi:10.3969/j.issn.1005-5304.2013.12.029]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(7):73.[doi:10.3969/j.issn.1005-5304.2013.12.029]
[2]范宏宇.肺癌咯血的中医治疗[J].中国中医药信息杂志,2009,16(5):82.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(7):82.
[3]王芬,周而复,陈文强,等.中晚期肺癌中医证候与患者生存质量关系的分析[J].中国中医药信息杂志,2007,14(2):21.
 WANG Fen,ZHOU Er-ful,CHEN Wen-qiang,et al.Analysis on the Correlation between the Principa1 Components of TCM Symptoms and the Quality of Life of the Middle-Advanced Stages Lung Caner Patients[J].zhongguo zhongyiyao xinxi zazhi,2007,14(7):21.
[4]王芳,花宝金,李丛煌.肺瘤平膏Ⅱ号合并化疗治疗非小细胞肺癌临床观察[J].中国中医药信息杂志,2009,16(9):53.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(7):53.
[5]李道睿,张培彤,胡晓梅,等.300例中晚期原发性支气管肺癌血瘀证分布规律的调查研究[J].中国中医药信息杂志,2007,14(3):19.
 LI Dao-rui,ZHANG Pei-tong,HU Xiao-mei,et al.Investigation of Distributing Characteristics of Blood Stasis Syndrome on 300 Cases of Advanced Stage Lung Cancer Patiens[J].zhongguo zhongyiyao xinxi zazhi,2007,14(7):19.
[6]闫向勇,孟庆常,燕忠生,等.岩舒注射液对肺癌放射性肺损伤的保护作用[J].中国中医药信息杂志,2008,15(4):82.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(7):82.
[7]樊春晓,崔蒙,于琦,等.基于中医药数据库的中医药治疗肺癌临床文献分析[J].中国中医药信息杂志,2011,18(5):27.[doi:10.3969/j.issn.1005-5304.2011.05.010]
 FAN Chun-xiao,CUI Meng,YU Qi,et al.Analysis on Clinical Literature of TCM for Lung Cancer in Recent Decade of Domestic Journals[J].zhongguo zhongyiyao xinxi zazhi,2011,18(7):27.[doi:10.3969/j.issn.1005-5304.2011.05.010]
[8]山广志,王海涛.黄枇烟吸入法治疗肺癌临床观察[J].中国中医药信息杂志,2011,18(8):77.[doi:10.3969/j.issn.1005-5304.2011.08.035]
[9]齐元富,李秀荣,李慧杰.大黄?虫丸治疗肺癌临床研究[J].中国中医药信息杂志,2011,18(11):15.[doi:10.3969/j.issn.1005-5304.2011.11.006]
 QI Yuan-fu,LI Xiu-rong,LI Hui-jie.Clinical Study on Lung Cancer Treated by Dahuang Zhechong Wan[J].zhongguo zhongyiyao xinxi zazhi,2011,18(7):15.[doi:10.3969/j.issn.1005-5304.2011.11.006]
[10]李丛煌,指导:花宝金.肺癌中医证候研究进展[J].中国中医药信息杂志,2007,14(8):95.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(7):95.

备注/Memo

基金项目:山西省卫生计生委科研课题(2017133)

更新日期/Last Update:

2020-06-19